Medicine

Niacin, food intake as well as cardiovascular impacts

.Attributes Medication, Released online: 05 September 2024 doi:10.1038/ s41591-024-03220-2Niacin, fo...

Opportunities and also difficulties for patient-reported outcome examination in multimorbidity research study and method

.Contending interests.S.E.H. acquires backing coming from the National Institute of Health and Treat...

Hibernation scientific research took advantage of to manage weight problems and customize metabolic rate

.Attribute Medication, Published online: 04 September 2024 doi:10.1038/ s41591-024-03226-wBy knowing...

CAR- T and cellular gene therapies are as well expensive

.Mother Nature Medicine, Published online: 04 September 2024 doi:10.1038/ s41591-024-03231-zPoint-of...

The WHO genomics plan of help nondiscriminatory application of individual genomics for global health

.The publication of the initial draft of the individual genome sequence in 20011 was followed by the...

A time-stratified, case\u00e2 $ \"crossover research study of heat energy exposure and perinatal death coming from 16 healthcare facilities in sub-Saharan Africa

.One of 138,015 hospital-based singleton childbirths in 4 sub-Saharan African countries, our team ob...

Advancing worldwide antibiotic study, development as well as gain access to #.\n\nMurray, C. J. L. et cetera. Global problem of microbial antimicrobial protection in 2019: an organized review. Lancet 399, 629\u00e2 $ \"655 (2022 ). AMR Frontrunnerses. Towards certain dedications and activity in the feedback to antimicrobial protection. International Leaders Team on Antimicrobial Protection https:\/\/www.amrleaders.org\/resources\/m\/item\/glg-report (4 April 2024). Planet Wellness Organization. That publishes checklist of micro-organisms for which brand new anti-biotics are actually urgently needed to have. World Wellness Institution https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed (27 February 2017). Globe Health And Wellness Company. That microbial priority pathogens checklist, 2024: bacterial pathogens of hygienics importance to assist analysis, growth as well as tactics to avoid as well as manage antimicrobial resistance. Globe Health Organization https:\/\/www.who.int\/publications\/i\/item\/9789240093461 (17 May 2024). Silver, L. L. A Gestalt way to Gram-negative entrance. Bioorg. Med. Chem. 24, 6379\u00e2 $ \"6389 (2016 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nSundqvist, M. Reversibility of antibiotic resistance. Ups. J. Medication. Sci. 119, 142\u00e2 $ \"148 (2014 ).\nGoogle.com Scholar\u00c2.\nWorld Health Association. 2023 antibacterial brokers in clinical as well as preclinical advancement: a summary and study. Planet Health and wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240094000 (14 June 2024). O' Neill, J. et al. AMR Review. May 19, 2016 \u00e2 $\" Handling drug-resistant diseases around the globe: ultimate document as well as recommendations. Testimonial on Antimicrobial Protection https:\/\/amr-review.org\/Publications.html (19 May 2016). Drive-AB Consortium. DRIVE-AB results: records and rundown. Drive abdominal https:\/\/drive-ab.eu\/drive-ab-outputs\/drive-ab-reports\/ (2016 ). Stern, S. et al. Breaking through the wall: an ask for collective action on prescription antibiotics research and development. Boston Consulting Group https:\/\/www.bundesgesundheitsministerium.de\/fileadmin\/Dateien\/5_Publikationen\/Gesundheit\/Berichte\/GUARD_Follow_Up_Report_Full_Report_final.pdf (February, 2017). Anderson, M., Panteli, D. &amp Mossialos, E. Plan Concise 51: Just how can the EU assistance lasting advancement and accessibility to effective antibiotics? plan alternatives for existing as well as brand-new medications. European Observatory on Health And Wellness Solutions and also Plans https:\/\/eurohealthobservatory.who.int\/publications\/i\/how-can-the-eu-support-sustainable-innovation-and-access-to-effective-antibiotics-policy-options-for-existing-and-new-medicines (21 June 2023). Turnidge, J. &amp Christiansen, K. Anti-biotic usage as well as resistance\u00e2 $\" showing the apparent. Lancet 365, 548\u00e2 $ \"549 (2005 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nGlobe Health Company. 2021 Mindful classification. WHO accessibility, check out, reserve, classification of antibiotics for examination and surveillance of making use of. World Health Organization https:\/\/www.who.int\/publications\/i\/item\/2021-aware-classification (30 September 2021). European Centre for Illness Deterrence and Control. Antimicrobial resistance intendeds: just how can our company reach all of them by 2030? ECDC https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/amr-brief-eaad-2023-update.pdf (2023 ). World Health And Wellness Institution. Absence of technology readied to undermine antibiotic efficiency and also health increases. Planet Wellness Organization https:\/\/www.who.int\/news\/item\/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains (22 June 2022). Magnano San, L. R. et cetera. Exactly how antimicrobial protection is actually connected to environment change: an overview of pair of intertwined worldwide obstacles. Int. J. Environ. Res. Hygienics twenty, 1681 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nDolecek, C., Shakoor, S., Basnyat, B., Okwor, T. &amp Sartorius, B. Drug-resistant microbial infections: we need emergency activity as well as assets that concentrate on the weakest hyperlink. PLoS Biol. Twenty, e3001903 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nGlobe Health Association. Booster shot coverage. Globe Health and wellness Company https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/immunization-coverage (15 July 2024). Chimhini, G., Magwenzi, M. &amp Fitzgerald, F. C. Disease deterrence and also control in low-resource settings: the necessity for the nearby, the contextual and the pragmatic. Affect. Prev. Pract. 4, 100135 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNour, S., Stokle, E., Ashiru-Oredope, D. &amp Wesangulae, E. Problems of applying antimicrobial stewardship devices in reduced to center income nations (LMICs). Infect. Prev. Pract. 5, 100315 (2023 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nAminov, R. A quick history of the antibiotic period: courses found out as well as problems for the future. Front end. Microbiol. 1, 134 (2010 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K. et al. Person get access to in 14 high-income countries to brand new antibacterials permitted by the United States Fda, European Medicines Organization, Japanese Pharmaceuticals and also Medical Equipment Organization, or even Wellness Canada, 2010\u00e2 $ \"2020. Clin. Corrupt. Dis. 74, 1183\u00e2 $ \"1190 (2022 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Health Association. 2021 antibacterial brokers in scientific and preclinical advancement: an outline and analysis. Globe Health and wellness Organization https:\/\/www.who.int\/publications\/i\/item\/9789240047655 (27 May 2022). Prescription antibiotics: the economics must support the scientific research. Attributes 625, 7 (2024 ). Thomas, D. &amp Wessel, C. The state of development in antibacterial rehabs. Biotechnology Innovation Company https:\/\/www.bio.org\/sites\/default\/files\/2022-02\/The-State-of-Innovation-in-Antibacterial-Therapeutics.pdf (February, 2022). Strich, J. et cetera. Examining medical professional utilization of next-generation prescription antibiotics against resistant Gram-negative contaminations in united state hospitals: a retrospective friend study. Ann. Intern. Med. 177, 559\u00e2 $ \"572 (2024 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nThomas, D. &amp Wessel, C. The condition of development in anti-bacterial therapeutics. Biotechnology Advancement Organization https:\/\/www.bio.org\/sites\/default\/files\/2022-04\/BIO-Antibacterial-Report-2022.pdf (February 2022). Renwick, M. J., Brogan, D. M. &amp Mossialos, E. An organized evaluation and essential examination of motivation tactics for exploration and also growth of novel anti-biotics. J. Antibiot. 69, 73\u00e2 $ \"88 (2016 ). Article\u00c2.\nCAS\u00c2.\n\nGoogle.com Scholar\u00c2.\nHealth And Wellness Urgent Readiness as well as Feedback Authority. R &amp d of health care countermeasures. International Compensation https:\/\/health.ec.europa.eu\/health-emergency-preparedness-and-response-hera\/preparedness\/research-and-development-medical-countermeasures_en (2024 ). International Compensation. Pre-draft plan for an European collaboration under Perspective Europe One Health And Wellness Antimicrobial Protection. International Payment https:\/\/research-and-innovation.ec.europa.eu\/system\/files\/2022-02\/ec_rtd_he-partnerships-onehealth-amr.pdf (9 February 2022). Worldwide Prescription Antibiotic Research and Development Relationship. Entasis Therapeutics and the Global Antibiotic Analysis &amp Progression Alliance to create a brand new treatment for gonorrhea. GARDP https:\/\/gardp.org\/entasis-therapeutics-and-the-global-antibiotic-research-development-partnership-to-develop-a-new-treatment-for-gonorrhea\/ (6 July 2017). Atal, I., Trinquart, L., Porcher, R. &amp Ravaud, P. Differential globalization of field- as well as non-industry-sponsored scientific trials. PLoS ONE 10, e0145122 (2015 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nPlanet Wellness Organization. Lot of scientific trial enrollments through location, illness, stage of development, age and sex of trial attendees (1999\u00e2 $ \"2022). Globe Wellness Institution https:\/\/www.who.int\/observatories\/global-observatory-on-health-research-and-development\/monitoring\/number-of-trial-registrations-by-year-location-disease-and-phase-of-development (February 2023). Worldwide Anti-biotic Trial And Error Relationship. NeoSept1: a research to identify the ranking of existing and brand-new antibiotics blends to handle newborn babies that reside in medical facility with extreme sepsis. ISRCTN pc registry https:\/\/www.isrctn.com\/ISRCTN48721236 (17 January 2022). Hygienics Agency of Canada. Federal government of Canada brings in necessary investment to fight antimicrobial protection (AMR), Federal government of Canada https:\/\/www.canada.ca\/en\/public-health\/news\/2023\/05\/government-of-canada-makes-important-investment-to-fight-antimicrobial-resistance-amr.html (11 May 2023). International Anti-biotic Experimentation Relationship. Asia government backing assists GARDP\u00e2 $ s efforts to respond to antibiotic resistance. GARDP https:\/\/gardp.org\/japan-government-funding-supports-gardps-efforts-to-counter-antibiotic-resistance\/ (19 Oct 2023). Novo Nordisk Foundation. Novo Nordisk Foundation companions with CARB-X to combat drug-resistant diseases. novo nordisk structure https:\/\/novonordiskfonden.dk\/en\/news\/novo-nordisk-foundation-partners-with-carb-x-to-fight-drug-resistant-infections\/ (9 January 2024). European Commission: European Health And Wellness and also Digital Manager Company. Study on bringing AMR medical countermeasures to the market place. Publications Workplace of the European Union https:\/\/op.europa.eu\/en\/publication-detail\/-\/publication\/51b2c82c-c21b-11ed-8912-01aa75ed71a1\/language-en (2023 ). Outterson, K. Approximating the suitable measurements of international pull rewards for antibacterial medications. Health and wellness Aff. 40, 1758\u00e2 $ \"1765 (2021 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nEvans, E. J., Meyer, A. &amp Conti, R. M. Sizing a market entry incentive for the advancement of brand new anti-biotics. Harvard Kennedy College https:\/\/www.hks.harvard.edu\/sites\/default\/files\/centers\/mrcbg\/Final_AWP_232.pdf (May 2024). Morel, C. M. et al. Market motivations as well as antibiotic resistance: an intro to the antibiotic susceptibility benefit. J. Antibiot. 73, 421\u00e2 $ \"428 (2020 ). CAS\u00c2.\n\nGoogle Scholar\u00c2.\nBonnifield, R. &amp Towse, A. An eager USG accelerated commitment for subscription-based purchasing of novel antimicrobials as well as its own anticipated roi. Center for Global Development https:\/\/www.cgdev.org\/publication\/ambitious-usg-advanced-commitment-subscription-based-purchasing-novel-antimicrobials (15 November 2022). Towse, A. &amp Silverman Bonnifield, R. G7 financial investments in new antibiotics will settle \u00e2 $\" for every person. Workplace of Health Economics https:\/\/www.ohe.org\/insight\/g7-investments-in-new-antibiotics-would-pay-off-for-everyone\/ (9 December 2022). NHS England. NHS improves struggle against dangerous infections adhering to successful world-first pilot. NHS England https:\/\/www.england.nhs.uk\/2023\/07\/nhs-steps-up-battle-against-life-threatening-infections-following-successful-world-first-pilot\/ (11 July 2023). United States Our lawmakers. S. 1355 \u00e2 $\" PASTEUR Process of 2023. congress.gov www.congress.gov\/bill\/118th-congress\/senate-bill\/1355#:~:text=This%20bill%20authorizes%20the%20Department,and%20contains%20other%20related%20provisions (27 April 2023). International Compensation. Reform of the EU pharmaceutical legalisation. European Payment https:\/\/health.ec.europa.eu\/medicinal-products\/pharmaceutical-strategy-europe\/reform-eu-pharmaceutical-legislation_en (26 April 2023). Gotham, D. et cetera. Reimbursement versions to tackle market breakdowns for antimicrobials: approaches absorbed France, Germany, Sweden, the United Kingdom, as well as the United States. Wellness Plan 125, 296\u00e2 $ \"306 (2020 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nInternational Alliance of Pharmaceutical Manufacturers and Organizations. From protection to durability: what could the future antibiotic pipeline appear like? IFMPA https:\/\/www.ifpma.org\/publications\/from-resistance-to-resilience-what-could-the-future-antibiotic-pipeline-look-like\/ (14 May 2024). International AMR R&ampD Center &amp Globe Wellness Association. Incentivising the advancement of brand new anti-bacterial procedures: 2023 report card by the International AMR R&ampD Center and WHO. International AMR R&ampD Hub https:\/\/globalamrhub.org\/publications\/incentivising-the-development-of-new-antibacterial-treatments-2023\/ (2023 ). Glover, R. E., Singer, A., Roberts, A. P. &amp Kirchhelle, C. Why is the UK membership model for antibiotics taken into consideration prosperous? Lancet Microorganism 4, e852\u00e2 $ \"e853 (2023 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nNon-paper \u00e2 $\" unique stimuli for the advancement as well as keeping the market place of antimicrobials. Politician https:\/\/www.politico.eu\/wp-content\/uploads\/2022\/12\/01\/Non-paper-Transferable-exclusivity-voucher-for-AMR-2.pdf (2022 ). Liu, L. et al. Global, local, and national root causes of kid death in 2000\u00e2 $ \"13, along with estimates to educate post-2015 concerns: an upgraded systematic review. Lancet 385, 430\u00e2 $ \"440 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nQuadri, F. et al. Antibacterial drug scarcities from 2001 to 2013: implications for medical application. Clin. Contaminate. Dis. 60, 1737\u00e2 $ \"1742 (2015 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nBenhabib, A. et cetera. The French coverage unit for drug deficiencies: explanation and fads from 2012 to 2018: an observational retrospective research study. BMJ Open 10, e034033 (2020 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nKlein, E. Y. et al. Evaluation of that antibiotic intake and also access aim ats in 76 countries, 2000\u00e2 $ \"15: a review of pharmaceutical sales information. Lancet Infect. Dis. 21, 107\u00e2 $ \"115 (2021 ). Article\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nPyzik, O. Z. &amp Abubakar, I. Dealing with the counterfeits: tackling shoddy and falsified medicines. Nat. Rev. Dis. Guides 8, 55 (2022 ). Hayhoe, B., Greenfield, G. &amp Majeed, A. Is it getting simpler to obtain anti-biotics in the UK? Br. J. Gen. Pract. 69, 54\u00e2 $ \"55 (2019 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrican Culture for Lab Medication. Plan quick and also infographics on antimicrobial resistance (AMR) in Africa. ASLM https:\/\/aslm.org\/resource\/policy-brief-and-infographics-on-antimicrobial-resistance-amr-in-africa\/ (14 September 2022). Kanu, J. S. et al. National antibiotic usage for human usage in Sierra Leone (2017\u00e2 $ \"2019): a cross-sectional research. Trop. Med. Infect. Dis. 6, 77 (2021 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nNamugambe, J. S. et cetera. National antimicrobial consumption: evaluation of core stockrooms products to in-patient care wellness centers from 2017 to 2019 in Uganda. Trop. Med. Corrupt. Dis. 6, 83 (2021 ).\nGoogle Scholar\u00c2.\nRobertson, J. et al. Varieties in the intake of antimicrobial medicines in the International region, 2014\u00e2 $ \"2018: searchings for and effects coming from ESAC-Net and also WHO Europe. Front. Pharmacol. 12, 639207 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nShukar, S. et al. Medication lack: triggers, influence, and also relief strategies. Front end. Pharmacol. 12, 693426 (2021 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle Scholar\u00c2.\nOutterson, K., Orubu, E. S. F., Rex, J., \u00c3 ... rdal, C. &amp Zaman, M. H. Individual gain access to in 14 high-income nations to new antibacterials accepted by the United States Food and Drug Administration, European Medicines Firm, Japanese Pharmaceuticals as well as Medical Equipment Company, or Health And Wellness Canada, 2010\u00e2 $ \"2020. Clin. Affect. Dis. 74, 1183\u00e2 $ \"1190 (2021 ). Article\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nPulcini, C. et al. Lost anti-biotics: a follow-up inventory study in Europe, the United States, Canada as well as Australia. Int. J. Antimicrob. Agents 49, 98\u00e2 $ \"101 (2017 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle Scholar\u00c2.\nRottingen, J. A. &amp Farrar, J. Targeted wellness advancement for international wellness. Br. Medication. J. 366, 15601 (2019 ).\nGoogle Scholar\u00c2.\nAMR Business Partnership. The 2023 AMR Field Partnership progress study: production and the atmosphere. amr Industry Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/12\/AMRIA_Manufacturing-and-the-environment-FINAL.pdf (2023 ). Munoz, V., Visentin, F., Venture, D. &amp Gaule, P. Can clinical products be actually established on a non-profit manner? Looking into product progression alliances for disregarded health conditions. Sci. Public Policy 42, 315\u00e2 $ \"338 (2015 ). Article\u00c2.\n\nGoogle.com Scholar\u00c2.\nSwaminathan, S. et al. Reboot biomedical R&ampD in the worldwide public rate of interest. Nature 602, 207\u00e2 $ \"210 (2022 ). Article\u00c2.\nCAS\u00c2.\nPubMed\u00c2.\n\nGoogle.com Scholar\u00c2.\nAfrica Centres for Health Condition Management as well as Protection. Africa CDC initiates strong move to protect Africa\u00e2 $ s wellness future by making a fifty billion dollar health care market. AfricaCDC https:\/\/africacdc.org\/news-item\/africa-cdc-spearheads-bold-move-to-secure-africas-health-future-by-creating-a-50-billion-dollar-medical-market\/ (19 February 2024). Carnage, C., Morin, S., R\u00c3 \u00b8 ttingen, J. A. &amp Kieny, M. P. Discussing public-health copyright licensing deals to improve accessibility to health and wellness technologies: an insider\u00e2 $ s tale. BMJ Chunk. Wellness 8, e012964 (2023 ). Article\u00c2.\nPubMed\u00c2.\nPubMed Central\u00c2.\n\nGoogle.com Scholar\u00c2.\nSuleman, F., Low, M., Moon, S. &amp Morgan, S. G. New business versions for r &amp d along with affordability demands are actually needed to have to achieve fair costs of medicines. Br. Med. J. 368, l4408 (2020 ). Article\u00c2.\n\nGoogle Scholar\u00c2.\nCombating Antibiotic-Resistant Germs Biopharmaceutical Gas. Conservation as well as accessibility. CARB-X https:\/\/carb-x.org\/about\/stewardship-and-access\/ (2024 ). International Anti-biotic Experimentation Collaboration. Shinogi, GARDP as well as CHAI introduce spots license and also cooperation arrangements to treat microbial contaminations next to expanding access to cefiderocol in 135 nations. GARDP https:\/\/gardp.org\/shionogi-gardp-and-chai-announce-landmark-license-and-collaboration-agreements-to-treat-bacterial-infections-by-expanding-access-to-cefiderocol-in-135-countries\/ (15 June 2022). AMR Industry Collaboration. Leaving the laboratory: tracking the decline in AMR R&ampD experts. amr Market Alliance https:\/\/www.amrindustryalliance.org\/wp-content\/uploads\/2023\/02\/Leaving-the-Lab_final-1.pdf (February, 2024). G7 Wellness Ministers. G7 Health Ministers\u00e2 $ Communiqu\u00c3 \u00a9. G7 Germany www.g7germany.de\/resource\/blob\/974430\/2042058\/5651daa321517b089cdccfaffd1e37a1\/2022-05-20-g7-health-ministers-communique-data.pdf (20 May 2022). G20. G20 call to activity on antimicrobial resistance. G7G20 Records Data source https:\/\/g7g20-documents.org\/database\/document\/2022-g20-indonesia-sherpa-track-health-ministers-ministers-annex-g20-call-to-action-on-antimicrobial-resistance (28 Oct 2022). Worldwide Coalition on Aging &amp Contagious Ailments Society of United States. 2024 AMR readiness index progress report. Assessing government action on AMR policy. International Union on Growing old https:\/\/globalcoalitiononaging.com\/wp-content\/uploads\/2024\/01\/2024-AMR-Index-Progress-Report.pdf (2024 ). Food as well as Farming Institution of the United Nations, United Nations Atmosphere Program, Planet Health Association &amp. World Company for Pet Wellness. International database for tracking antimicrobial protection (AMR): country self-assessment poll (TrACSS). That https:\/\/amrcountryprogress.org\/

/map-viewindicator2.3 (2023 ). Vehicle Katwyk, S. R. &amp Outterson K. Introduction: AMR belongs in ...

Integrating liver endpoints in professional trials of heart and also renal ailment

.Attributes Medicine, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspec...

FALSE:: ERROR: UNSUPPORTED ENCODING...

Artificial intelligence guided testing for cardiomyopathies in an obstetric population: a practical randomized scientific trial

.Trial design as well as oversightThe Testing for PEripartum Cardiomyopathies with Artificial Intell...